- Home
- CVRX vs QTRX Comparison
CVRX vs QTRX Comparison
Compare CVRX & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- QTRX
- Stock Information
- Founded
- CVRX 2000
- QTRX 2007
- Country
- CVRX United States
- QTRX United States
- Employees
- CVRX N/A
- QTRX N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- CVRX Health Care
- QTRX Industrials
- Exchange
- CVRX Nasdaq
- QTRX Nasdaq
- Market Cap
- CVRX 181.5M
- QTRX 233.5M
- IPO Year
- CVRX 2021
- QTRX 2017
- Fundamental
- Price
- CVRX $6.45
- QTRX $5.26
- Analyst Decision
- CVRX Buy
- QTRX Buy
- Analyst Count
- CVRX 7
- QTRX 5
- Target Price
- CVRX $14.50
- QTRX $15.60
- AVG Volume (30 Days)
- CVRX 516.1K
- QTRX 676.0K
- Earning Date
- CVRX 05-08-2025
- QTRX 05-12-2025
- Dividend Yield
- CVRX N/A
- QTRX N/A
- EPS Growth
- CVRX N/A
- QTRX N/A
- EPS
- CVRX N/A
- QTRX N/A
- Revenue
- CVRX $52,870,000.00
- QTRX $135,688,000.00
- Revenue This Year
- CVRX $13.92
- QTRX N/A
- Revenue Next Year
- CVRX $19.89
- QTRX $14.75
- P/E Ratio
- CVRX N/A
- QTRX N/A
- Revenue Growth
- CVRX 25.62
- QTRX 7.71
- 52 Week Low
- CVRX $4.30
- QTRX $4.05
- 52 Week High
- CVRX $18.55
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- CVRX 44.02
- QTRX 47.68
- Support Level
- CVRX $6.08
- QTRX $4.96
- Resistance Level
- CVRX $7.17
- QTRX $5.40
- Average True Range (ATR)
- CVRX 0.57
- QTRX 0.44
- MACD
- CVRX 0.14
- QTRX 0.08
- Stochastic Oscillator
- CVRX 65.03
- QTRX 61.71
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.